US Patent Issued to Eli Lilly and Co. on Oct. 7 for "Indazole derivatives as inhibitors of SARM1" (British, American Inventors)

ALEXANDRIA, Va., Oct. 8 -- United States Patent no. 12,435,084, issued on Oct. 7, was assigned to Eli Lilly and Co. (Indianapolis).

"Indazole derivatives as inhibitors of SARM1" was invented by Jonathan Bentley (Abingdon, Great Britain), Shelley Anne Parrott (Abingdon, Great Britain), Andrew Simon Brearley (Chilton, Great Britain), Todd Bosanac (New Milford, Conn.), Robert Owen Hughes (Newtown, Conn.) and Rajesh Devraj (Chesterfield, Mo.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides compounds of formula (I) and methods useful for inhibiting SARM1 and/or treating and/or preventing axonal degeneration."

The patent was filed on April 7, 2021, under Application No. 17/995,046. ...